The global burden of women’s cancers: a grand challenge in global health
暂无分享,去创建一个
Richard Sullivan | Lesong Conteh | Malabika Sarker | M. Coleman | F. Bray | L. Conteh | J. Gralow | G. Parham | K. Yeates | R. Sullivan | O. Ginsburg | S. Kotha | C. Allemani | M. Sarker | Michel P Coleman | Karen Yeates | Freddie Bray | V. Vanderpuye | A. Eniu | T. Huong | A. Dvaladze | Carolyn Taylor | N. Oomman | S. Krishnan | Dominista Kombe | M. Blas | Natasha Kassami | Claudia Allemani | Julie Gralow | Suneeta Krishnan | Alexandru Eniu | Nandini Oomman | Ophira Ginsburg | Verna Vanderpuye | S Rani Kotha | Tran Thanh Huong | Allison Dvaladze | Carolyn Taylor | Dominista Kombe | Magaly M Blas | Groesbeck Parham | Natasha Kassami | R. Sullivan
[1] A. Hailu,et al. Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study , 2013, BMC Cancer.
[2] D. Roy. Breast cancer in developing countries. , 1982 .
[3] Umberto Veronesi,et al. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. , 2015, The Lancet. Oncology.
[4] D. Parkin,et al. Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010 , 2013, International journal of cancer.
[5] M. Chávez-MacGregor,et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data , 2011 .
[6] G. Colditz,et al. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Coleman,et al. Is England closing the international gap in cancer survival? , 2015, British Journal of Cancer.
[8] Zhao Chen,et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. , 2005, Journal of the National Cancer Institute.
[9] M. Plummer,et al. Time since first sexual intercourse and the risk of cervical cancer , 2012, International journal of cancer.
[10] E. Chang,et al. Disparities in breast cancer survival among Asian women by ethnicity and immigrant status: a population-based study. , 2010, American journal of public health.
[11] Stéphane Verguet,et al. Disease Control Priorities in Developing Countries , 2015 .
[12] C. Mathers,et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions , 2012, The Lancet.
[13] P. Rochon,et al. A population-based study of ethnicity and breast cancer stage at diagnosis in Ontario. , 2015, Current oncology.
[14] D. Endrei,et al. Annual Health Insurance Cost of Breast Cancer Treatment in Hungary. , 2014, Value in Health.
[15] D. Fisman,et al. Relative risk of cervical cancer in indigenous women in Australia, Canada, New Zealand, and the United States: A systematic review and meta-analysis , 2012, Journal of public health policy.
[16] H. Adami,et al. International incidence rates of invasive cervical cancer before cytological screening , 1997 .
[17] G. Abdulrahman,et al. Epidemiology of Breast Cancer in Europe and Africa , 2012, Journal of cancer epidemiology.
[18] O. Franco,et al. Cervical cancer in Indigenous women: The case of Australia. , 2011, Maturitas.
[19] F. Bray,et al. Survival disparities in Australia: an analysis of patterns of care and comorbidities among indigenous and non-indigenous cancer patients , 2014, BMC Cancer.
[20] R. Atun,et al. Improving responsiveness of health systems to non-communicable diseases , 2013, The Lancet.
[21] F. Knaul,et al. Women's Health Beyond Reproduction: Meeting the Challenges , 2012, Bulletin of the World Health Organization.
[22] J. Githaiga,et al. Comparative study of breast cancer risk factors at Kenyatta National Hospital and the Nairobi Hospital , 2015 .
[23] A. Gumber,et al. Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics , 2008, BMC public health.
[24] A. Feigl,et al. The Global Economic Burden of Noncommunicable Diseases , 2012 .
[25] R. Moineddin,et al. Predictors of low cervical cancer screening among immigrant women in Ontario, Canada , 2011, BMC women's health.
[26] Laura D'Andrea Tyson,et al. The global gender gap report. 2010. , 2011 .
[27] D. Parkin,et al. Trends in the incidence of cancer in Kampala, Uganda 1991–2010 , 2014, International journal of cancer.
[28] A. Derossis,et al. Is Breast Cancer the Same Disease in Asian and Western Countries? , 2010, World Journal of Surgery.
[29] J. Ferlay,et al. Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration , 2015, International journal of cancer.
[30] P. Sheehan,et al. Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework , 2013, The Lancet.
[31] J. Yang. Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases , 2016 .
[32] J. Church. Human Development Report , 2001 .
[33] C. Bewtra. Clinicopathologic Features of Female Breast Cancer in Kumasi, Ghana , 2010 .
[34] F. Knaul. WOMEN ’ S REPRODUCTIVE HEALTH IN TRANSITION : THE OVERLAPPING CHALLENGE OF BREAST AND CERVICAL CANCER , 2014 .
[35] M. Coory,et al. Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study , 2006, The Lancet.
[36] M. Woodward. The economic cost of cancer to patients and their families in South-East Asia. , 2014 .
[37] S. Connor,et al. Global atlas of palliative care at the end of life , 2018 .
[38] M. Siahpush,et al. Global Inequalities in Cervical Cancer Incidence and Mortality are Linked to Deprivation, Low Socioeconomic Status, and Human Development , 2012, International journal of MCH and AIDS.
[39] Sharon Friel,et al. Closing the gap in a generation: health equity through action on the social determinants of health , 2008, The Lancet.
[40] G. Sen,et al. Women and Health: the key for sustainable development , 2015, The Lancet.
[41] C. Perou,et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.
[42] The Agecode Study Group. Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries , 2015 .
[43] T. Ansari,et al. The financial burden of cancer: Estimates from patients undergoing cancer care in a tertiary care hospital , 2012, International Journal for Equity in Health.
[44] K. Znati,et al. [Epidemiological and biologic profile of breast cancer in Fez-Boulemane, Morocco]. , 2011, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
[45] HPV, HIV and cervical cancer: leveraging synergies to save women’s lives , 2017 .
[46] C J L M Meijer,et al. The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.
[47] Gretchen A. Stevens,et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.
[48] E. Trimble,et al. Changing global policy to deliver safe, equitable, and affordable care for women’s cancers , 2017, The Lancet.
[49] Abdul-Rasheed K. Adesunkanmi,et al. The severity, outcome and challenges of breast cancer in Nigeria. , 2006, Breast.
[50] Ping Sun,et al. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. , 2015, JAMA.
[51] Gavin Yamey,et al. Global health 2035: a world converging within a generation , 2013, The Lancet.
[52] Charles Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[53] R. Peto,et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. , 2012, Lancet.
[54] M. Manyama,et al. Pathological features of Breast Cancer seen in Northwestern Tanzania: a nine years retrospective study , 2011, BMC Research Notes.
[55] Laura D'Andrea Tyson,et al. The global gender gap report , 2006 .
[56] R. Love,et al. Breast Cancer: A Neglected Disease for the Majority of Affected Women Worldwide , 2011, The breast journal.
[57] M. Shrime,et al. The Lancet Oncology Commission Global cancer surgery: delivering safe, aff ordable, and timely cancer surgery , 2015 .
[58] A. Sreedevi,et al. Epidemiology of cervical cancer with special focus on India , 2015, International journal of women's health.
[59] M. Davari,et al. The direct medical costs of breast cancer in Isfahan-Iran , 2012 .
[60] Hutcha Sriplung,et al. Cancer survival in Africa, Asia, and Central America: a population-based study. , 2010, The Lancet. Oncology.
[61] D. Flum,et al. Guideline‐concordant cancer care and survival among American Indian/Alaskan Native patients , 2014, Cancer.
[62] S. Sanjosé,et al. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries , 2017, The Lancet.
[63] S. Gomez,et al. Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[64] Jennifer S. Smith,et al. Incidence and progression of cervical lesions in women with HIV: a systematic global review , 2014, International journal of STD & AIDS.
[65] A. Jemal,et al. Breast Cancer Incidence Rates in U.S. Women Are No Longer Declining , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[66] Breakaway : The global burden of cancer — challenges and opportunities , 2009 .
[67] M. Davari,et al. The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient's Level Data from a Cancer Specific Hospital in Isfahan , 2013, International journal of preventive medicine.
[68] A. Jemal,et al. Breast cancer survival in Ethiopia: A cohort study of 1,070 women , 2014, International journal of cancer.
[69] F. Bray,et al. Cancer incidence in indigenous people in Australia, New Zealand, Canada, and the USA: a comparative population-based study. , 2015, The Lancet. Oncology.
[70] F. Bray,et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. , 2016, The Lancet. Global health.
[71] S. Newmann,et al. Social inequities along the cervical cancer continuum: a structured review , 2005, Cancer Causes & Control.
[72] J. Griggs,et al. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[74] A. Boutayeb,et al. Estimation of the cost of treatment by chemotherapy for early breast cancer in Morocco , 2010, Cost effectiveness and resource allocation : C/E.
[75] Junior Bazile,et al. Intergenerational impacts of maternal mortality: Qualitative findings from rural Malawi , 2015, Reproductive Health.
[76] M. Coleman,et al. Cancer survival differences between South Asians and non-South Asians of England in 1986–2004, accounting for age at diagnosis and deprivation , 2015, British Journal of Cancer.
[77] Jeffrey H Silber,et al. Characteristics associated with differences in survival among black and white women with breast cancer. , 2013, JAMA.
[78] P. Porter,et al. "Westernizing" women's risks? Breast cancer in lower-income countries. , 2008, The New England journal of medicine.
[79] L. Bogaert. Age at diagnosis of preinvasive and invasive cervical neoplasia in South Africa: HIV-positive versus HIV-negative women. , 2011 .
[80] David A Jaffray,et al. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition , 2016, The Lancet.
[81] Jennifer Leaning,et al. Consequences of maternal mortality on infant and child survival: a 25-year longitudinal analysis in Butajira Ethiopia (1987-2011) , 2015, BMC Genomics.
[82] R. Sullivan,et al. 114INESMO EUROPEAN CONSORTIUM STUDY ON THE AVAILABILITY OF ANTI-NEOPLASTIC MEDICINES ACROSS EUROPE. , 2014, Annals of Oncology.
[83] D. Forman,et al. Cancer in indigenous people in Latin America and the Caribbean: a review , 2013, Cancer medicine.
[84] F. Bray,et al. Costs , aff ordability , and feasibility of an essential package of cancer control interventions in low-income and middle-income countries : key messages from Disease Control Priorities , 3 rd edition , 2015 .
[85] J. Ranstam,et al. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease , 2002, The Lancet.
[86] R. Salamon,et al. Direct costs of cervical cancer management in Morocco. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[87] N. Muñoz,et al. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. , 2003, Journal of the National Cancer Institute. Monographs.
[88] D. Bakker,et al. Factors influencing mammography participation in Canada: an integrative review of the literature , 2009, Current oncology.
[89] M. Holmes,et al. Disparities across the breast cancer continuum , 2005, Cancer Causes & Control.
[90] P. Coyte,et al. Cost of treatment for breast cancer in central Vietnam , 2013, Global health action.
[91] S. Garg,et al. Expenditure audit of women with breast cancer in a tertiary care hospital of Delhi. , 2011, Indian journal of cancer.
[92] Dan J Stein,et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[93] S. Ayaya,et al. Nutritional Status of Orphaned and Separated Children and Adolescents Living in Community and Institutional Environments in Uasin Gishu County, Kenya , 2013, PloS one.
[94] Michael Baumann,et al. Expanding global access to radiotherapy. , 2015, The Lancet. Oncology.
[95] M. Coleman,et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. , 2014, The Lancet. Oncology.
[96] E. Matos,et al. The socio-economic impact of cervical cancer on patients and their families in Argentina, and its influence on radiotherapy compliance. Results from a cross-sectional study. , 2007, Gynecologic oncology.
[97] M. Poljak,et al. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia. , 2013, Vaccine.
[98] Heather Eliassen,et al. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies , 2012, The Lancet. Oncology.
[99] S. Goldie,et al. Cost Effectiveness and Resource Allocation Open Access Estimating the Cost of Cervical Cancer Screening in Five Developing Countries , 2006 .
[100] M. Whitehead,et al. The concepts and principles of equity and health. , 1992, International journal of health services : planning, administration, evaluation.
[101] Helena Carreira,et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) , 2015, The Lancet.
[102] G. Maskarinec,et al. Ethnic Differences in Breast Cancer Survival: Status and Determinants , 2011, Women's health.